LTBK-01: PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Roger Stupp; Ahmed Idbaih; David M. Steinberg; William Read; Steven Toms; Gene Barnett; Garth Nicholas; Chae-Yong Kim; Karen Fink; Andrea Salmaggi; Frank Lieberman; Jay Zhu; Lynne Taylor; Giuseppe Stragliotto; Andreas Hottinger; Eilon D. Kirson; Uri Weinberg; Yoram Palti; Monika E. Hegi; Zvi Ram;

doi:10.1093/neuonc/now260

LTBK-01: PROSPECTIVE, MULTI-CENTER PHASE III TRIAL OF TUMOR TREATING FIELDS TOGETHER WITH TEMOZOLOMIDE COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Neuro-Oncology ◽

10.1093/neuonc/now260 ◽

2016 ◽

Vol 18 (suppl_6) ◽

pp. i1-i1 ◽

Cited By ~ 13

Author(s):

Roger Stupp ◽

Ahmed Idbaih ◽

David M. Steinberg ◽

William Read ◽

Steven Toms ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Newly Diagnosed Glioblastoma

Download Full-text

QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL

Neuro-Oncology ◽

10.1093/neuonc/nox168.834 ◽

2017 ◽

Vol 19 (suppl_6) ◽

pp. vi206-vi206

Author(s):

Martin J B Taphoorn ◽

Linda Dirven ◽

Sophie Taillibert ◽

Jerôme Honnorat ◽

Thomas Chen ◽

...

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Newly Diagnosed Glioblastoma

Download Full-text

Abstract CT007: Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial

10.1158/1538-7445.am2017-ct007 ◽

2017 ◽

Cited By ~ 6

Author(s):

Roger Stupp ◽

Monika E. Hegi ◽

Ahmed Idbaih ◽

David M. Steinberg ◽

Benoit Lhermitte ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Standard Chemotherapy ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Newly Diagnosed Glioblastoma

Download Full-text

Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma

Journal of Neuro-Oncology ◽

10.1007/s11060-017-2601-y ◽

2017 ◽

Vol 135 (3) ◽

pp. 545-552 ◽

Cited By ~ 16

Author(s):

Jay-Jiguang Zhu ◽

◽

Petya Demireva ◽

Andrew A. Kanner ◽

Susan Pannullo ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Cognitive Screening ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Newly Diagnosed Glioblastoma

Download Full-text

Abstract CT204: Increasing Tumor Treating Fields dose at the tumor bed improves survival: Setting a framework for TTFields dosimetry based on analysis of the EF-14 Phase III trial in newly diagnosed glioblastoma

10.1158/1538-7445.am2019-ct204 ◽

2019 ◽

Author(s):

Matthew T. Ballo ◽

Noa Urman ◽

Ze'ev Bomzon ◽

Gitit Lavy-Shahaf ◽

Steven Toms

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

Tumor Bed ◽

Tumor Treating Fields ◽

Newly Diagnosed Glioblastoma

Download Full-text

Tumor treating fields (TTFields): A novel treatment modality added to standard chemo- and radiotherapy in newly diagnosed glioblastoma—First report of the full dataset of the EF14 randomized phase III trial.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.2000 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 2000-2000 ◽

Cited By ~ 5

Author(s):

Roger Stupp ◽

Sophie Taillibert ◽

Andrew Kanner ◽

Santosh Kesari ◽

Steven A Toms ◽

...

Keyword(s):

Treatment Modality ◽

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

First Report ◽

Tumor Treating Fields ◽

Full Dataset ◽

Novel Treatment ◽

Newly Diagnosed Glioblastoma

Download Full-text

Effects of Tumor Treating Fields (TTFields) on Health-Related Quality of Life (HRQOL) in Newly Diagnosed Glioblastoma: An Exploratory Analysis of the EF-14 Randomized Phase III Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.036 ◽

2018 ◽

Vol 102 (3) ◽

pp. S170-S171 ◽

Cited By ~ 1

Author(s):

S.A. Toms

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Newly Diagnosed Glioblastoma

Download Full-text

Abstract CT204: Increasing Tumor Treating Fields dose at the tumor bed improves survival: Setting a framework for TTFields dosimetry based on analysis of the EF-14 Phase III trial in newly diagnosed glioblastoma

10.1158/1538-7445.sabcs18-ct204 ◽

2019 ◽

Author(s):

Matthew T. Ballo ◽

Noa Urman ◽

Ze'ev Bomzon ◽

Gitit Lavy-Shahaf ◽

Steven Toms

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Phase Iii Trial ◽

Tumor Bed ◽

Tumor Treating Fields ◽

Newly Diagnosed Glioblastoma

Download Full-text

QOLP-01. EFFECTS OF TUMOR TREATING FIELDS ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA: AN EXPLORATORY ANALYSIS OF THE EF-14 RANDOMIZED PHASE III TRIAL

Neuro-Oncology ◽

10.1093/neuonc/noy148.887 ◽

2018 ◽

Vol 20 (suppl_6) ◽

pp. vi214-vi214

Author(s):

Tobias Walbert ◽

Gitit Lavy-Shahaf

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Newly Diagnosed Glioblastoma

Download Full-text

P01.057 Effects of tumor treating fields on health-related quality of life (HRQoL) in newly diagnosed glioblastoma: An exploratory analysis of the EF-14 randomized phase III trial

Neuro-Oncology ◽

10.1093/neuonc/noy139.099 ◽

2018 ◽

Vol 20 (suppl_3) ◽

pp. iii242-iii242

Author(s):

T Walbert ◽

G Lavy-Shahaf ◽

Keyword(s):

Quality Of Life ◽

Phase Iii ◽

Newly Diagnosed ◽

Health Related Quality ◽

Phase Iii Trial ◽

Tumor Treating Fields ◽

Related Quality ◽

Health Related ◽

Newly Diagnosed Glioblastoma

Download Full-text

OC-0333 Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)06866-3 ◽

2021 ◽

Vol 161 ◽

pp. S246-S247

Author(s):

A. Laprie ◽

G. Noel ◽

L. Chaltiel ◽

G. Truc ◽

M. Sunyach ◽

...

Keyword(s):

Phase Iii ◽

Newly Diagnosed ◽

Dose Painting ◽

Phase Iii Trial ◽

Multicenter Phase ◽

Newly Diagnosed Glioblastoma

Download Full-text